GL
OREX

GLG LLC’s Orexigen Therapeutics, Inc. OREX Stock Holding History

GLG LLC’s Portfolio OREX Stock Details OREX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$1.97M Buy
+1,524,143
New +$2.48M 0.14% 181
2017
Q2 		– Sell
-250,172
Closed -$861K – 595
2017
Q1 		$861K Buy
250,172
+222,372
+800% +$878K 0.05% 359
2016
Q4 		$48K Buy
+27,800
New +$65.3K ﹤0.01% 509

Other funds holding OREX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
OWIM
Old West Investment Management Los Angeles, California $923M AUM 112.31% 1-Year Est. Return

GLG LLC's OREX Position: Q4 2017 in Review

GLG LLC opened a new position in Orexigen Therapeutics, Inc. (OREX) in Q4 2017: 1,524,143 shares worth $1.97M. The stake represents 0.14% of the portfolio and ranks #181 among its holdings. This is a return to the name: GLG LLC previously reported a position in OREX as recently as Q1 2017.

GLG LLC first reported a position in OREX in Q4 2016 and has held it in 3 quarters since. 41 funds tracked by Wall St. Rank hold OREX as of Q4 2017.

  • GLG LLC held 1,524,143 shares of Orexigen Therapeutics, Inc. worth $1.97M as of Q4 2017.
  • Orexigen Therapeutics, Inc. was a new GLG LLC position in Q4 2017.
  • Orexigen Therapeutics, Inc. made up 0.14% of GLG LLC's portfolio in Q4 2017, its #181 holding.
  • GLG LLC first reported a position in Orexigen Therapeutics, Inc. in Q4 2016 and has held it in 3 quarters since.
  • 41 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q4 2017.

Based on GLG LLC's 13F filing for Q4 2017, filed 14 Feb 2018.